Balance Sheet Concord Biotech Limited

Equities

CONCORDBIO

INE338H01029

Pharmaceuticals

Delayed NSE India S.E. Other stock markets 04:35:03 13/03/2026 pm IST			5-day change	1st Jan Change
1,182.20 ^INR	+0.66%		-2.07%	-12.14%

13/02	Jefferies Adjusts Concord Biotech's Price Target to INR1,170 From INR1,290, Keeps at Hold	MT
12/02	Concord Biotech Limited, Q3 2026 Earnings Call, Feb 12, 2026

ab1311104f4.KqwijNXkeWhP0VoiFrg8nftJPkDvWQOwRiNYundPhV8.ZMQPv4aHOhgCnG8TRuhE76sMdwuiF3WGL0Jo5RkgtHJG3Re0l64TBAOVPQ

Published financial data: CONCORD BIOTECH LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	616.4Cr	712.93Cr	853.17Cr	1.02TCr	1.2TCr
Total Revenues	616.4Cr	712.93Cr	853.17Cr	1.02TCr	1.2TCr
Cost of Goods Sold, Total	116.94Cr	171.92Cr	192.08Cr	244.78Cr	431.73Cr
Gross Profit	499.46Cr	541.01Cr	661.09Cr	772.16Cr	768.36Cr
Selling General & Admin Expenses, Total	70Cr	96Cr	110.29Cr	123.07Cr	138.93Cr
Provision for Bad Debts	48.85L	-	-	-	-
Depreciation & Amortization - (IS)	28Cr	50Cr	54Cr	54Cr	54Cr
Other Operating Expenses	99Cr	166.25Cr	197.34Cr	208.73Cr	114.95Cr
Other Operating Expenses, Total	197.22Cr	311.99Cr	361.66Cr	385.39Cr	308.26Cr
Operating Income	302.24Cr	229.02Cr	299.42Cr	386.76Cr	460.1Cr
Interest Expense, Total	-52.32L	-5.48Cr	-4.51Cr	-2.55Cr	-52.93L
Interest And Investment Income	1.79Cr	4.79Cr	4.44Cr	3.04Cr	1.71Cr
Net Interest Expenses	1.26Cr	-69.7L	-7L	48.92L	1.18Cr
Income (Loss) On Equity Invest.	-44.91L	-3.64Cr	1.96Cr	3.37Cr	-1.32Cr
Currency Exchange Gains (Loss)	1.55Cr	6.36Cr	10Cr	6.48Cr	8.2Cr
Other Non Operating Income (Expenses)	1.12Cr	97.3L	6.2Cr	1.24Cr	4.35Cr
EBT, Excl. Unusual Items	305.73Cr	232.02Cr	317.74Cr	398.35Cr	472.51Cr
Gain (Loss) On Sale Of Investments	6.99Cr	5.23Cr	3.72Cr	14Cr	22Cr
Gain (Loss) On Sale Of Assets	-	-3L	-9L	1L	-22.47L
Insurance Settlements	29T	30.3L	65.1L	14.14L	9T
EBT, Incl. Unusual Items	312.72Cr	237.52Cr	322.01Cr	412.56Cr	494.55Cr
Income Tax Expense	78Cr	63Cr	82Cr	104.46Cr	122.91Cr
Earnings From Continuing Operations	234.89Cr	174.93Cr	240.09Cr	308.1Cr	371.64Cr
Net Income to Company	234.89Cr	174.93Cr	240.09Cr	308.1Cr	371.64Cr
Net Income - (IS)	234.89Cr	174.93Cr	240.09Cr	308.1Cr	371.64Cr
Net Income to Common Incl Extra Items	234.89Cr	174.93Cr	240.09Cr	308.1Cr	371.64Cr
Net Income to Common Excl. Extra Items	234.89Cr	174.93Cr	240.09Cr	308.1Cr	371.64Cr
Per Share Items
Net EPS - Basic	22.45	16.72	22.95	29.45	35.52
Basic EPS - Continuing Operations	22.45	16.72	22.95	29.45	35.52
Basic Weighted Average Shares Outstanding	10Cr	10Cr	10Cr	10Cr	10Cr
Net EPS - Diluted	22.45	16.72	22.95	29.45	35.52
Diluted EPS - Continuing Operations	22.45	16.72	22.95	29.45	35.52
Diluted Weighted Average Shares Outstanding	10Cr	10Cr	10Cr	10Cr	10Cr
Normalized Basic EPS	18.26	13.86	18.98	23.8	28.23
Normalized Diluted EPS	18.26	13.86	18.98	23.8	28.23
Dividend Per Share	6.74	5.12	6.83	8.75	10.7
Payout Ratio	2.43	40.31	22.31	23.19	24.63
Supplemental Items
EBITDA	328.57Cr	277.82Cr	352.21Cr	438.62Cr	512.71Cr
EBITA	305.34Cr	232.26Cr	302.66Cr	387.05Cr	460.4Cr
EBIT	302.24Cr	229.02Cr	299.42Cr	386.76Cr	460.1Cr
EBITDAR	328.57Cr	277.82Cr	352.22Cr	438.64Cr	-
Total Revenues (As Reported)	630.51Cr	736.35Cr	888.48Cr	1.05TCr	1.24TCr
Effective Tax Rate - (Ratio)	24.89	26.35	25.44	25.32	24.85
Total Current Taxes	76Cr	58Cr	80Cr	100Cr	118.96Cr
Total Deferred Taxes	2.34Cr	3.7Cr	2.38Cr	4.63Cr	3.95Cr
Normalized Net Income	191.08Cr	145.01Cr	198.59Cr	248.97Cr	295.32Cr
Interest on Long-Term Debt	39.86L	31.4L	18.19L	2.28Cr	47.55L
Non-Cash Pension Expense	1L	2L	6L	4L	3L
Supplemental Operating Expense Items
Marketing Expenses	93.27L	-	-	-	-
Selling and Marketing Expenses	93.27L	-	-	-	-
Research And Development Expense From Footnotes	-	-	33Cr	23Cr	27Cr
Net Rental Expense, Total	44T	20T	71T	2L	-
Imputed Operating Lease Interest Expense	2.61T	11.56T	54.48T	2L	-
Imputed Operating Lease Depreciation	41.39T	8.44T	16.52T	2.2T	-
Maintenance & Repair Expenses, Total	5.37Cr	7.91Cr	12Cr	16Cr	14Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	5.14Cr	66.7L	3.5Cr	15Cr	90.45L
Short Term Investments	55Cr	87Cr	31Cr	23Cr	18Cr
Trading Asset Securities, Total	140.99Cr	73Cr	136.93Cr	243.7Cr	316.54Cr
Total Cash And Short Term Investments	201.13Cr	161.39Cr	171.01Cr	281.67Cr	335.44Cr
Accounts Receivable, Total	177.52Cr	232.17Cr	273.76Cr	349.61Cr	521.65Cr
Other Receivables	36Cr	27Cr	22Cr	16Cr	21Cr
Total Receivables	213.34Cr	259.45Cr	295.55Cr	365.61Cr	542.7Cr
Inventory	153.61Cr	195.12Cr	212.31Cr	207.95Cr	239.67Cr
Prepaid Expenses	4.54Cr	4.76Cr	5.52Cr	7.33Cr	7.39Cr
Other Current Assets, Total	35Cr	12Cr	43Cr	34Cr	10Cr
Total Current Assets	607.14Cr	632.67Cr	727.7Cr	896.23Cr	1.14TCr
Gross Property Plant And Equipment	650.16Cr	781.4Cr	952.79Cr	1.02TCr	1.13TCr
Accumulated Depreciation	-92Cr	-137.85Cr	-187.31Cr	-238.46Cr	-288.67Cr
Net Property Plant And Equipment	557.75Cr	643.56Cr	765.48Cr	786.48Cr	844.22Cr
Long-term Investments	36.57L	25.6L	12.46L	2.07Cr	23Cr
Other Intangibles, Total	6.42Cr	3.58Cr	19.77L	31.97L	1.12Cr
Other Long-Term Assets, Total	11Cr	33Cr	20Cr	16Cr	31Cr
Total Assets	1.18TCr	1.31TCr	1.51TCr	1.7TCr	2.03TCr
Liabilities
Accounts Payable, Total	46Cr	83Cr	94Cr	94Cr	113.04Cr
Accrued Expenses, Total	10Cr	13Cr	15Cr	17Cr	19Cr
Short-term Borrowings	5.1Cr	4.34Cr	-	-	38.11L
Current Portion of Long-Term Debt	25Cr	25Cr	25Cr	6.23Cr	-
Current Portion of Leases	1.3Cr	1.6Cr	14.69L	1.62Cr	1.96Cr
Current Income Taxes Payable	-	-	9Cr	5.49Cr	10Cr
Unearned Revenue Current, Total	-	3.27Cr	1.31Cr	-	-
Other Current Liabilities	18Cr	25Cr	48Cr	18Cr	39Cr
Total Current Liabilities	105.74Cr	155.17Cr	191.84Cr	142.16Cr	184.06Cr
Long-Term Debt	56Cr	31Cr	6.24Cr	-	-
Long-Term Leases	1.63Cr	31.1L	16.38L	1.89Cr	62.98L
Deferred Tax Liability Non Current	17Cr	21Cr	23Cr	28Cr	34Cr
Other Non Current Liabilities	2.1Cr	1.87Cr	2.3Cr	1.96Cr	2.82Cr
Total Liabilities	183.17Cr	209.57Cr	223.98Cr	174.06Cr	221.53Cr
Common Stock, Total	9.51Cr	9.51Cr	10Cr	10Cr	10Cr
Additional Paid In Capital	83Cr	83Cr	82Cr	82Cr	82Cr
Retained Earnings	906.94Cr	1.01TCr	1.2TCr	1.43TCr	1.72TCr
Total Common Equity	999.37Cr	1.1TCr	1.29TCr	1.53TCr	1.81TCr
Total Equity	999.37Cr	1.1TCr	1.29TCr	1.53TCr	1.81TCr
Total Liabilities And Equity	1.18TCr	1.31TCr	1.51TCr	1.7TCr	2.03TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	10Cr	10Cr	10Cr	10Cr	10Cr
ECS Total Common Shares Outstanding	10Cr	10Cr	10Cr	10Cr	10Cr
Book Value / Share	95.53	105.45	123.31	145.93	173.27
Tangible Book Value	992.95Cr	1.1TCr	1.29TCr	1.53TCr	1.81TCr
Tangible Book Value Per Share	94.91	105.11	123.29	145.9	173.17
Total Debt	89Cr	62Cr	32Cr	9.74Cr	2.97Cr
Net Debt	-111.85Cr	-99Cr	-139.46Cr	-271.93Cr	-332.47Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	22.13L	93.5L	57.67L	42.7L	58.03L
Debt Equivalent Oper. Leases	4L	2L	6L	16L	-
Equity Method Investments, Total	36.57L	-	-	2.06Cr	73.65L
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	65Cr	81Cr	80Cr	63Cr	80Cr
Inventories - Work In Process, Total	68Cr	90Cr	113.2Cr	123.48Cr	133.83Cr
Inventories - Finished Goods, Total	20Cr	22Cr	15Cr	17Cr	21Cr
Inventories - Others	58.4L	1.94Cr	3.89Cr	4.57Cr	4.82Cr
Land - (BS)	55Cr	55Cr	55Cr	55Cr	63Cr
Buildings, Total	198.08Cr	222.63Cr	246.29Cr	257.57Cr	355.33Cr
Machinery, Total	377.28Cr	428.54Cr	478.83Cr	497.91Cr	662.16Cr
Full Time Employees	-	1.18T	-	1.38T	1.57T
Accumulated Allowance for Doubtful Accounts (Supple)	1.13Cr	78.1L	87.3L	1.39Cr	3.18Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	234.89Cr	174.93Cr	240.09Cr	308.1Cr	371.64Cr
Depreciation & Amortization - CF	24Cr	47Cr	51Cr	53Cr	54Cr
Amortization of Goodwill and Intangible Assets - (CF)	3.1Cr	3.24Cr	3.24Cr	28.99L	30.1L
Depreciation & Amortization, Total	27Cr	50Cr	54Cr	54Cr	54Cr
Amortization of Deferred Charges, Total - (CF)	15.41L	15.5L	13.89L	5L	1L
(Gain) Loss From Sale Of Asset	-	3L	9L	-1L	22.47L
(Gain) Loss on Sale of Investments - (CF)	-6.99Cr	-5.23Cr	-3.72Cr	-14Cr	-22Cr
(Income) Loss On Equity Investments - (CF)	44.91L	3.64Cr	-1.96Cr	-3.37Cr	1.32Cr
Provision and Write-off of Bad Debts	45.99L	-34.6L	9L	66.94L	1.78Cr
Other Operating Activities, Total	-75.15L	6.45Cr	12Cr	1.73Cr	8.19Cr
Change In Accounts Receivable	6.5Cr	-53Cr	-43Cr	-79Cr	-170.79Cr
Change In Inventories	-42Cr	-42Cr	-17Cr	4.36Cr	-32Cr
Change In Accounts Payable	-23Cr	37Cr	9.88Cr	-11Cr	22Cr
Change in Other Net Operating Assets	-30Cr	36Cr	-1.84Cr	4.41Cr	9.65Cr
Cash from Operations	166.81Cr	207.48Cr	248.3Cr	265.47Cr	244.52Cr
Capital Expenditure	-204.42Cr	-155.5Cr	-145.08Cr	-86Cr	-111.17Cr
Sale of Property, Plant, and Equipment	-	6L	3L	17.51L	19.9L
Investment in Marketable and Equity Securities, Total	8.87Cr	40Cr	-18Cr	-72Cr	-60Cr
Other Investing Activities, Total	10.7L	4.14Cr	5.58Cr	2.77Cr	11Cr
Cash from Investing	-195.44Cr	-111.79Cr	-157.95Cr	-154.61Cr	-159.99Cr
Short Term Debt Issued, Total	5.1Cr	-	-	-	-
Long-Term Debt Issued, Total	52Cr	-	-	-	-
Total Debt Issued	57Cr	-	-	-	-
Short Term Debt Repaid, Total	-	-76.1L	-	-	-
Long-Term Debt Repaid, Total	-20Cr	-27Cr	-27Cr	-27Cr	-6.75Cr
Total Debt Repaid	-20Cr	-27Cr	-27Cr	-27Cr	-6.75Cr
Common Dividends Paid	-5.71Cr	-71Cr	-54Cr	-71Cr	-92Cr
Common & Preferred Stock Dividends Paid	-5.71Cr	-71Cr	-54Cr	-71Cr	-92Cr
Other Financing Activities, Total	-15.75L	-2.23Cr	-54.07L	-1.26Cr	-48.35L
Cash from Financing	31Cr	-100.16Cr	-81Cr	-99Cr	-99Cr
Miscellaneous Cash Flow Adjustments	-	-	-6.63Cr	-	-
Net Change in Cash	2.74Cr	-4.48Cr	2.83Cr	12Cr	-14Cr
Supplemental Items
Cash Interest Paid	15.75L	5.32Cr	3.78Cr	2.65Cr	63.32L
Cash Income Tax Paid (Refund)	75Cr	61Cr	70Cr	103.35Cr	109.42Cr
Levered Free Cash Flow	-83Cr	19Cr	50Cr	117.77Cr	93Cr
Unlevered Free Cash Flow	-83Cr	22Cr	53Cr	119.36Cr	93Cr
Change In Net Working Capital	95Cr	15Cr	43Cr	90Cr	137.82Cr
Net Debt Issued / Repaid	37Cr	-27Cr	-27Cr	-27Cr	-6.75Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	17.8	11.47	13.24	15.04	15.4
Return on Total Capital	19.77	12.7	15.05	16.92	17.16
Return On Equity %	26.55	16.64	20.06	21.88	22.26
Return on Common Equity	26.55	16.64	20.06	21.88	22.26
Margin Analysis
Gross Profit Margin %	81.03	75.89	77.49	75.93	64.03
SG&A Margin	11.42	13.42	12.93	12.1	11.58
EBITDA Margin %	53.3	38.97	41.28	43.13	42.72
EBITA Margin %	49.54	32.58	35.48	38.06	38.36
EBIT Margin %	49.03	32.12	35.1	38.03	38.34
Income From Continuing Operations Margin %	38.11	24.54	28.14	30.3	30.97
Net Income Margin %	38.11	24.54	28.14	30.3	30.97
Net Avail. For Common Margin %	38.11	24.54	28.14	30.3	30.97
Normalized Net Income Margin	31	20.34	23.28	24.48	24.61
Levered Free Cash Flow Margin	-13.54	2.65	5.9	11.58	7.72
Unlevered Free Cash Flow Margin	-13.48	3.13	6.23	11.74	7.74
Asset Turnover
Asset Turnover	0.58	0.57	0.6	0.63	0.64
Fixed Assets Turnover	1.31	1.19	1.21	1.31	1.47
Receivables Turnover (Average Receivables)	3.41	3.48	3.37	3.26	2.75
Inventory Turnover (Average Inventory)	0.88	0.99	0.94	1.16	1.93
Short Term Liquidity
Current Ratio	5.74	4.08	3.79	6.3	6.17
Quick Ratio	3.92	2.71	2.43	4.55	4.77
Operating Cash Flow to Current Liabilities	1.58	1.34	1.29	1.87	1.33
Days Sales Outstanding (Average Receivables)	106.89	104.87	108.22	112.18	132.49
Days Outstanding Inventory (Average Inventory)	413.31	370.19	387.11	314.19	189.22
Average Days Payable Outstanding	134.75	110.74	154.27	143.28	81.7
Cash Conversion Cycle (Average Days)	385.45	364.33	341.06	283.09	240.01
Long Term Solvency
Total Debt/Equity	8.93	5.66	2.45	0.64	0.16
Total Debt / Total Capital	8.2	5.36	2.39	0.63	0.16
LT Debt/Equity	5.79	2.86	0.5	0.12	0.03
Long-Term Debt / Total Capital	5.32	2.71	0.48	0.12	0.03
Total Liabilities / Total Assets	15.49	15.96	14.79	10.23	10.89
EBIT / Interest Expense	577.67	41.76	66.39	151.56	869.27
EBITDA / Interest Expense	629.98	50.86	78.34	172.54	971.97
(EBITDA - Capex) / Interest Expense	239.28	22.5	46.17	138.96	761.93
Total Debt / EBITDA	0.27	0.22	0.09	0.02	0.01
Net Debt / EBITDA	-0.34	-0.35	-0.39	-0.62	-0.65
Total Debt / (EBITDA - Capex)	0.71	0.51	0.15	0.03	0.01
Net Debt / (EBITDA - Capex)	-0.89	-0.8	-0.67	-0.77	-0.82
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	20.31	15.56	19.67	19.2	18.01
Gross Profit, 1 Yr. Growth %	33.46	8.2	22.19	16.8	15.16
EBITDA, 1 Yr. Growth %	53.5	-15.48	26.78	24.38	16.9
EBITA, 1 Yr. Growth %	57.39	-23.97	30.31	27.7	18.96
EBIT, 1 Yr. Growth %	55.79	-24.26	30.74	28.98	18.97
Earnings From Cont. Operations, 1 Yr. Growth %	38.89	-25.53	37.25	28.33	20.62
Net Income, 1 Yr. Growth %	38.89	-25.53	37.25	28.33	20.62
Normalized Net Income, 1 Yr. Growth %	51.98	-24.11	36.94	25.36	18.62
Diluted EPS Before Extra, 1 Yr. Growth %	38.89	-25.52	37.25	28.33	20.62
Accounts Receivable, 1 Yr. Growth %	-3.26	30.79	17.91	27.71	49.21
Inventory, 1 Yr. Growth %	38.1	27.02	8.81	-2.05	15.25
Net Property, Plant and Equip., 1 Yr. Growth %	46.42	15.38	18.95	2.74	7.34
Total Assets, 1 Yr. Growth %	25.73	11.01	15.33	12.33	19.61
Tangible Book Value, 1 Yr. Growth %	28.93	10.74	17.29	18.34	18.69
Common Equity, 1 Yr. Growth %	29.75	10.39	16.93	18.34	18.74
Cash From Operations, 1 Yr. Growth %	7.76	24.37	19.29	7.91	-7.89
Capital Expenditures, 1 Yr. Growth %	31.49	-23.84	-6.7	-40.94	29.74
Levered Free Cash Flow, 1 Yr. Growth %	-	-122.71	166.37	132.77	-21.34
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-126.96	138.1	123.47	-22.12
Dividend Per Share, 1 Yr. Growth %	63.87	-24.05	33.4	28.11	22.29
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	17.96	17.6	19.43	18.6
Gross Profit, 2 Yr. CAGR %	-	20.23	14.99	19.47	7.81
EBITDA, 2 Yr. CAGR %	-	13.93	3.51	25.65	20.58
EBITA, 2 Yr. CAGR %	-	9.42	-0.46	29.09	23.25
EBIT, 2 Yr. CAGR %	-	8.65	-0.49	29.95	23.87
Earnings From Cont. Operations, 2 Yr. CAGR %	-	1.71	1.1	32.71	24.42
Net Income, 2 Yr. CAGR %	-	1.71	1.1	32.71	24.42
Normalized Net Income, 2 Yr. CAGR %	-	7.4	1.94	31.03	21.94
Diluted EPS Before Extra, 2 Yr. CAGR %	-	1.7	1.11	32.71	24.42
Accounts Receivable, 2 Yr. CAGR %	-	12.48	24.18	22.71	38.04
Inventory, 2 Yr. CAGR %	-	32.44	17.57	3.24	6.25
Net Property, Plant and Equip., 2 Yr. CAGR %	-	29.98	17.15	10.55	5.02
Total Assets, 2 Yr. CAGR %	-	18.14	13.15	13.82	15.92
Tangible Book Value, 2 Yr. CAGR %	-	19.49	13.97	17.81	18.51
Common Equity, 2 Yr. CAGR %	-	19.68	13.61	17.64	18.54
Cash From Operations, 2 Yr. CAGR %	-	15.75	22	12.93	-0.3
Capital Expenditures, 2 Yr. CAGR %	-	0.01	-15.7	-25.77	-12.46
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-22.23	149.69	35.3
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-19.88	131.27	31.91
Dividend Per Share, 2 Yr. CAGR %	-	11.56	0.66	30.73	25.16
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	18.53	18.13	18.96
Gross Profit, 3 Yr. CAGR %	-	-	20.88	15.59	12.4
EBITDA, 3 Yr. CAGR %	-	-	18.06	10.09	22.66
EBITA, 3 Yr. CAGR %	-	-	15.98	8.21	25.62
EBIT, 3 Yr. CAGR %	-	-	15.57	8.55	26.18
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	12.39	9.47	28.55
Net Income, 3 Yr. CAGR %	-	-	12.39	9.47	28.55
Normalized Net Income, 3 Yr. CAGR %	-	-	16.46	9.22	26.75
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	12.39	9.47	28.55
Accounts Receivable, 3 Yr. CAGR %	-	-	14.26	25.35	30.98
Inventory, 3 Yr. CAGR %	-	-	24.05	10.62	7.1
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	26.19	12.14	9.47
Total Assets, 3 Yr. CAGR %	-	-	17.2	12.88	15.72
Tangible Book Value, 3 Yr. CAGR %	-	-	18.75	15.41	18.11
Common Equity, 3 Yr. CAGR %	-	-	18.76	15.17	18
Cash From Operations, 3 Yr. CAGR %	-	-	17.05	16.75	5.52
Capital Expenditures, 3 Yr. CAGR %	-	-	-2.28	-25.13	-10.58
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	12.28	69.88
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	12.98	60.89
Dividend Per Share, 3 Yr. CAGR %	-	-	18.41	9.08	27.85
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	18.56
Gross Profit, 5 Yr. CAGR %	-	-	-	-	15.47
EBITDA, 5 Yr. CAGR %	-	-	-	-	19.09
EBITA, 5 Yr. CAGR %	-	-	-	-	18.87
EBIT, 5 Yr. CAGR %	-	-	-	-	18.85
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	17.06
Net Income, 5 Yr. CAGR %	-	-	-	-	17.06
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	18.62
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	17.06
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	23.24
Inventory, 5 Yr. CAGR %	-	-	-	-	16.59
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	17.25
Total Assets, 5 Yr. CAGR %	-	-	-	-	16.68
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	18.66
Common Equity, 5 Yr. CAGR %	-	-	-	-	18.67
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	9.57
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	-6.49
Dividend Per Share, 5 Yr. CAGR %	-	-	-	-	21.07